101.png

Our Farmers

We partner with independent farmers who are passionate about cultivating healthy, sustainable crops that promote the health of families globally and also preserve our ocean’s ecosystems.  Working closely with our trained agronomists, they strictly follow our Crop Assured 365® system, a promise that your omegas are naturally authentic, from soil to oil.

Our Team

Our NCI team is passionate about what we do and why we do it. Our “why” is simple. Ahiflower is a balancing force in nutritional health, ocean abundance, and agricultural stewardship. We are grateful that we have the opportunity to be a part of something that is so inspiring and fulfilling.

Andrew Hebard   President and CEO

Andrew Hebard

President and CEO

Greg Cumberford   Director of Science and Regulatory Affairs

Greg Cumberford

Director of Science and Regulatory Affairs

Brandi Dupuis   Director of Finance

Brandi Dupuis

Director of Finance

Simon Meakin   UK Operations and Agronomy Manager

Simon Meakin

UK Operations and Agronomy Manager

Lindsay Cole   Marketing Manager

Lindsay Cole

Marketing Manager

Crystal Cormier   General Manager

Crystal Cormier

General Manager

Justin   Burt   Logistics and Account Manager

Justin Burt

Logistics and Account Manager

Sarah Ramsay   Finance Assistant

Sarah Ramsay

Finance Assistant

Terence McGeown   Lab Manager

Terence McGeown

Lab Manager

Kaitlin Delaney   Lab Technician

Kaitlin Delaney

Lab Technician

Garth Cole   Production Manager

Garth Cole

Production Manager

Dylan Garnhum   Processing Technician

Dylan Garnhum

Processing Technician

Denis Gignac   Processing Technician

Denis Gignac

Processing Technician

Hugo Rousseaux-Bridle   Processing Technician

Hugo Rousseaux-Bridle

Processing Technician

Kevin LaBobe   Processing Technician

Kevin LaBobe

Processing Technician

 
 
 

Our Advisors

Drawing on some of the best health, environmental, agricultural and scientific experts, we have established breadth and depth of wisdom, life experience and professional expertise on our advisory team. This group assures that we are supplying you premium value ingredients from the plants that we cultivate under contract.

MarcSurrett.jpg

Dr. Marc E. Surette, PhD. Dr. Marc Surette is a professor of Biochemistry at Université de Moncton, Canada. Dr. Surette earned a BSc and MSc from Dalhousie University in Halifax Nova Scotia, and a PhD from Cornell University in Ithaca, New York. He did post-doctoral training at the Centre Hospitalier de l’Université Laval in Québec City, and at Wake Forest University School of Medicine in North Carolina. Dr Surette spent nearly 5 years with a biopharmaceutical company in North and South Carolina as Director and then as Vice-President of Research and Development, before returning to Canada as a Professor and Canada Research Chair at Université de Moncton. In 2015 he was named the New Brunswick Innovation Research Chair in Biosciences.

Dr. Surette and his team conduct biomedical health research in the field of cellular lipid metabolism. His research program encompasses both fundamental discovery as well as applied research projects that include the development and testing of new pharmaceutical agents and the investigation of sustainable sources of omega-3 fatty acid from agriculture. Dr. Surette is the inventor on 4 issued patents, has authored over 80 peer-reviewed publications and has presented over 100 Conference and invited communications.

Dr. William Harris holds a PhD in Nutritional Biochemistry from the University of Minnesota. Since 1980, his research has focused on omega-3 fatty acids and human lipid metabolism, platelet function, cardiovascular and neurocognitive disease. He has been on the medical faculties of Kansas University, the University of Missouri-Kansas City, and is currently at the University of South Dakota. He has been the principal investigator on 5 omega-3 related NIH grants and has published over 200 papers on omega-3.  As of December 2016, Dr. Harris was the most published omega-3 researcher in the world. In 2004 he and his colleague Dr. Clemens von Schacky proposed that the “Omega-3 Index” (RBC EPA+DHA) be considered as a new risk factor, for not only cardiovascular but also neurocognitive diseases. In 2009, he founded a company (OmegaQuant Analytics, LLC) to offer the test to researchers, healthcare providers and consumers. Dr. Harris is the President of OmegaQuant Analytics.

“After having done several studies on SDA-enriched oils derived from genetically-modified soybeans, I have become convinced that SDA is essentially a “pro-EPA” molecule, i.e., a readily-converted source for this long-chain omega-3 typically derived from fish oils. However, with the widespread suspicion of GMO products, another source for SDA needed to be discovered. This is what excites me about Ahiflower oil, which is a truly natural source of SDA that is also commercially practical. The day when we can of raise EPA levels on a population basis by fortifying a wide variety of foods with products like Ahiflower oil is now on the horizon.”

“After having done several studies on SDA-enriched oils derived from genetically-modified soybeans, I have become convinced that SDA is essentially a “pro-EPA” molecule, i.e., a readily-converted source for this long-chain omega-3 typically derived from fish oils. However, with the widespread suspicion of GMO products, another source for SDA needed to be discovered. This is what excites me about Ahiflower oil, which is a truly natural source of SDA that is also commercially practical. The day when we can of raise EPA levels on a population basis by fortifying a wide variety of foods with products like Ahiflower oil is now on the horizon.”

AlexRichardson.png

Dr. Alexandra Richardson is best known for her research into how nutrition (and particularly fatty acids) can affect behaviour, learning and mood, although her work also involves several large-scale collaborative programmes that include studies of epidemiology, genetics, brain imaging, biochemistry and nutrition as well as physiological and psychological functioning. Her current research centres on the role of fatty acids in relation to both normal individual differences and developmental and psychiatric disorders such as dyslexia, dyspraxia, ADHD, autism, depression and schizophrenia. Recent and ongoing work includes controlled treatment trials to investigate the effects of dietary supplementation with fatty acids in relation to features of these conditions, experimental studies of possible underlying mechanisms, and collaborative investigations of the epidemiology and genetics of neurodevelopmental disorders.

Alex has more than 80 research publications in peer-reviewed journals and academic books. She is also the author of They Are What You Feed Them - a widely-acclaimed book written for parents and professionals that explains how and why children's diets can affect their behaviour, learning and mood, and offers easy-to-follow practical advice based on the latest scientific evidence.